mehmet nur kaya | rheumatology | Best Researcher Award

Dr. mehmet nur kaya | rheumatology | Best Researcher Award

Dr at gülhane training and research hospital, Turkey

The study titled “Impact of Central Sensitization on Clinical and Functional Aspects of Psoriatic Arthritis” by Mehmet Nur Kaya et al. examines the prevalence of central sensitization (CS) in patients with psoriatic arthritis (PsA). Conducted with 103 PsA patients, the research used the Central Sensitization Inventory (CSI) to assess CS’s influence on clinical and functional markers such as disease activity, sleep quality, depression, and anxiety. The study found that 65.1% of the patients had CS, with the Psoriasis Area Severity Index (PASI), General Anxiety Disorder-7 (GAD-7), and Insomnia Severity Index (ISI) emerging as significant predictors of CS. Patients with CS demonstrated higher BMI and disease activity scores. The research highlights the importance of considering CS when assessing pain sensitivity in PsA patients. These findings underscore the potential impact of CS on clinical management, with implications for treatment strategies aimed at improving quality of life in PsA patients.

 

Publication profile

Scopus

🎓 Education

Dr. Mehmet Nur Kaya is a distinguished researcher in rheumatology, having earned his medical degree from a reputable institution. He pursued further specialization in rheumatology and is currently affiliated with the Rheumatology Department at Gülhane Training and Research Hospital, University of Health Sciences in Turkey. His commitment to understanding complex rheumatic diseases, especially psoriatic arthritis (PsA), reflects his dedication to advancing medical knowledge through continuous learning and hands-on experience.

👨‍⚕️ Professional Experience

As a dedicated rheumatologist, Dr. Kaya has extensive experience in the study and management of PsA and other rheumatic conditions. His contributions to understanding the clinical and functional impacts of central sensitization (CS) on PsA patients are significant. He has led numerous observational studies focusing on pain sensitivity, quality of life, disease activity, and treatment outcomes. Utilizing patient-centric assessments like the Central Sensitization Inventory (CSI), Dr. Kaya has shaped treatment protocols, improving patient care and outcomes. His commitment to clinical expertise and research continues to enhance the quality of life for individuals affected by chronic inflammatory diseases.

🔬 Research Skills

Dr. Kaya possesses essential research skills that include:

Critical Thinking: Evaluating sources and synthesizing diverse viewpoints. Methodology Proficiency: Designing studies and collecting valid data using quantitative and qualitative approaches. Effective Communication: Clearly articulating findings through written reports and presentations. Organizational Skills: Managing research timelines and resources efficiently. Digital Tool Familiarity: Accessing and utilizing a wide range of resources. Ethical Considerations: Upholding integrity and confidentiality in research.

 

Publication

  1. Indices and ferritin level that predict organ involvement in adult-onset Still’s disease
    Authors: Kaya, M.N., Kılıç, Ö., Güneş, E.Ç., Tecer, D., Yılmaz, S.
    Journal: Biomarkers in Medicine, 2024
    Citations: 0

 

  1. Drug-free remission is an achievable target with immunosuppressive treatment in idiopathic granulomatous mastitis
    Authors: Kaya, M.N., Tekgöz, E., Çolak, S., Çınar, M., Yılmaz, S.
    Journal: Irish Journal of Medical Science, 2023, 192(6), pp. 2815–2819
    Citations: 3

 

  1. Can pre-treatment inflammatory biomarker levels predict the response of tocilizumab therapy in COVID-19 patients?
    Authors: Kaya, M.N., Tecer, D., Çınar, M., Çolak, S., Yılmaz, S.
    Journal: Gulhane Medical Journal, 2023, 65(4), pp. 145–151
    Citations: 1

 

  1. Hospital-acquired anemia in chronic kidney disease
    Authors: Kaya, M.N., Caner, B., Toprak, Ö.
    Journal: International Journal of Scientific and Technology Research, 2019, 8(4), pp. 160–166
    Citations: 0

🔍 Conclusion

Dr. Mehmet Nur Kaya is a dedicated and accomplished rheumatologist whose extensive clinical experience and significant research contributions make him an excellent candidate for the Best Researcher Award. His strengths, particularly in patient-centric research and commitment to advancing medical knowledge, position him as a leader in the field of rheumatology. By focusing on expanding his publication record, seeking funding opportunities, and fostering collaborative initiatives, Dr. Kaya can further elevate his contributions to rheumatology and improve the lives of those affected by chronic inflammatory diseases. His innovative approaches and commitment to patient care underscore his potential to make a lasting impact in the field.

Teng Zhang | Gynecologic Oncology | Young Scientist Award

Ms. ‌Teng Zhang |Gynecologic Oncology |Young Scientist Award 

Ms at Qilu Hospital of Shandong University, China

Ms. Teng Zhang is an accomplished Attending Doctor in the Department of Obstetrics and Gynecology at Qilu Hospital of Shandong University. With a Ph.D. and Master’s degree from Cheeloo College of Medicine, Shandong University, and a Bachelor’s degree from Jining Medical College, Ms. Zhang has extensive experience in clinical practice and research. Notable achievements include publications on cervical cancer in high-impact journals and awards in English teaching competitions. Dr. Zhang’s research focuses on fertility-sparing treatments, m6A methylation, and immune cell variations in cervical cancer, underscoring a strong commitment to advancing women’s health.

Profile

 

🎓 Education Background

Sept. 2015 – Sep. 2018: Ph.D., Cheeloo College of Medicine, Shandong University. Sept. 2013 – Sep. 2015: Master, Cheeloo College of Medicine, Shandong University. Sept. 2008 – Jun. 2013: Bachelor of Medicine, Jining Medical College. Sept. 2005 – Jun. 2008: Qingdao No.2 Middle School

💼 Research/Work Experience

July 2022 – Present: Attending Doctor, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University. Nov. 2018 – June 2021: Resident, Department of Gynecology and Obstetrics, Qilu Hospital of Shandong University. June 2016 – June 2017: Visiting Scholar, Griffith University, Australia

🏆 Scholarships and Awards

2023: Young Teachers English Teaching Competition, Second Prize, Cheeloo College of Medicine, Shandong University, 2021: The First “Guangzhi Cup” English Teaching Competition in Qilu Hospital of Shandong University, Third Prize, July 2013: Excellent Graduate of Shandong Province, Oct. 2009: National Scholarship

Publications Top Notes 📝

  • Xuji Jiang, Chuanli Feng, Wanying Sun, Teng Zhang*, Baoxia Cui. “The top 100 most cited articles on fertility-sparing treatments for cervical cancer: A bibliometric analysis.” Heliyon, 10(11), 2024.

 

  • Zhonghao Mao, Bingyu Wang, Teng Zhang, Baoxia Cui*. “The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications.” Cell Death and Disease, 2023, 14(734).

 

  • Teng Zhang, Jun Jiao, Xinlin Jiao, Lu Zhao, Xinli Tian, Qing Zhang, Daoxin Ma, Baoxia Cui*. “Aberrant frequency of TNFR2+ Treg and related cytokines in patients with CIN and cervical cancer.” Oncotarget, 2017, 9(4).

 

  • Bingyu Wang, Zhonghao Mao, Jinwen Ye, Xinlin Jiao, Teng Zhang, Qi Wang, Sai Han, Youzhong Zhang, Chunling Wang, Taotao Dong, Baoxia Cui. “Glycolysis Induced by METTL14 Is Essential for Macrophage Phagocytosis and Phenotype in Cervical Cancer.” The Journal of Immunology, 2024, 15(212).

 

  • Zhang W, Tian X, Mumtahana F, Jiao J, Zhang T, Croce K.D., Cui B*. “The existence of Th22, pure Th17 and Th1 cells in CIN and Cervical Cancer along with their frequency variation in different stages of cervical cancer.” BMC Cancer, 2015, 15,717.

 

  • Jun Jiao, Teng Zhang, Xinlin Jiao, Tingting Huang, Lu Zhao, Daoxin Ma, Baoxia Cui*. “hsa_circ_0000745 promotes cervical cancer by increasing cell proliferation, migration, and invasion.” J Cell Physiol, 2019, 1-9.

 

  • Xinlin Jiao, Siying Zhang, Jun Jiao, Teng Zhang, Wenjie Qu, Guy Mutangala Muloye, Beihua Kong, Qing Zhang, Baoxia Cui*. “Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance.” Clin Epigenetics, 2019, 11(120).